CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at $56.83 ($127,870)
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale SVP, Finance & CAO sold 3,000 shares at $60.00 ($180,000)
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $58.43 ($131,476)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SVP, Finance & CAO sold 1,892 shares at an average $55.57 ($105,147)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Technical Ops Officer gave up 604 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 3,685 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 1,021 shares (to pay taxes)
Page 5 of 39 · 770 filings